Tag: CHAIR

UBC’s Dr. Devon Greyson named 2024 Applied Public Health Chair

Dr. Devon Greyson, an assistant professor at the UBC Faculty of Medicine’s School of Population and Public Health, has been appointed an Applied Public Health Chair by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC).

Dr. Devon Greyson

Dr. Greyson is among 12 Canadian scholars named to the 2024 cohort of the program. The Chairs are supported over six years by a $13.8 million investment from the Government of Canada through CIHR and PHAC.

Dr. Greyson is a leading expert in public health communications. Their Chair, titled “Building Trusted Population Health Information Systems and Interventions,” will address barriers to vaccination by filling knowledge gaps on effective health communication interventions, with the aim to build trusted public health information systems and interventions in order to mitigate the dangers of misinformation. The Chair is funded by the Centre for Research on Pandemic Preparedness and Health Emergencies.

Dr. Greyson, also an investigator with the Vaccine Evaluation Center at BC Children’s Hospital Research Institute, is a health information scientist who applies qualitative, multiple, and mixed methods to understand health information behaviour and to assess effectiveness of population health information interventions. Their current research focuses largely on vaccination, including improving vaccine communication and vaccine safety and coverage surveillance.

The Applied Public Health Chairs program was established in 2008 to support creating public health solutions informed by the best available scientific evidence. The 2024 Chairs will continue that critical work on the most critical areas of public health in Canada. With the knowledge they gain through their research, the Chairs and their teams will work with decision makers, both within and outside of the public health sector, to contribute to the development of solutions to some of Canada’s biggest public health

UBC’s Dr. Devon Greyson named 2024 Applied Public Health Chair

Dr. Devon Greyson, an assistant professor at the UBC Faculty of Medicine’s School of Population and Public Health, has been appointed an Applied Public Health Chair by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC).

Dr. Devon Greyson

Dr. Greyson is among 12 Canadian scholars named to the 2024 cohort of the program. The Chairs are supported over six years by a $13.8 million investment from the Government of Canada through CIHR and PHAC.

Dr. Greyson is a leading expert in public health communications. Their Chair, titled “Building Trusted Population Health Information Systems and Interventions,” will address barriers to vaccination by filling knowledge gaps on effective health communication interventions, with the aim to build trusted public health information systems and interventions in order to mitigate the dangers of misinformation. The Chair is funded by the Centre for Research on Pandemic Preparedness and Health Emergencies.

Dr. Greyson, also an investigator with the Vaccine Evaluation Center at BC Children’s Hospital Research Institute, is a health information scientist who applies qualitative, multiple, and mixed methods to understand health information behaviour and to assess effectiveness of population health information interventions. Their current research focuses largely on vaccination, including improving vaccine communication and vaccine safety and coverage surveillance.

The Applied Public Health Chairs program was established in 2008 to support creating public health solutions informed by the best available scientific evidence. The 2024 Chairs will continue that critical work on the most critical areas of public health in Canada. With the knowledge they gain through their research, the Chairs and their teams will work with decision makers, both within and outside of the public health sector, to contribute to the development of solutions to some of Canada’s biggest public health

Announcement: Dr. David A. Steven re-appointed chair Department of Clinical Neurological Sciences – Schulich School of Medicine & Dentistry

david-steven-200x250.png

We are pleased to announce that Dr. David A. Steven has been re-appointed to the Department of Clinical Neurological Sciences as:

• Chair (Schulich School of Medicine & Dentistry, Western University);
• Physician Department Executive (London Health Sciences Centre); and
• Chief (St. Joseph’s Health Care London).

The re-appointment will be effective January 1, 2024, to December 31, 2028.

Dr. Steven earned his Bachelor of Science in 1992 and MD in 1996 from the University of Manitoba. He then went on to complete his residency in neurosurgery at the Schulich School of Medicine and Dentistry at Western University in 2002, followed by a fellowship in epilepsy surgery at the Montréal Neurological Institute. Dr. Steven also obtained his Masters of Public Health from Yale University during his residency.

Dr. Steven joined the Department of Clinical Neurological Sciences at Schulich Medicine & Dentistry in 2003, where he is currently a Professor. He holds a cross-appointment in the Department of Epidemiology and Biostatistics. Dr. Steven holds the Richard Ivey Chair in Clinical Neurological Sciences as the Chair of the Department. He will be renewed in the Endowed Chair through his term as the Chair.

Dr. Steven is also a neurosurgeon at LHSC and an Associate Scientist at Lawson Health Research Institute.

Dr. Steven is dedicated to residency and fellowship education. He has served as Director of the neurosurgery residency program and directs the epilepsy surgery fellowship at Schulich Medicine and Dentistry at Western University. The residency program is one-of-its-kind premiere fellowship in Canada, with fellows from all over the world being trained in London.

Nationally, Dr. Steven is closely associated with the Royal College of Physicians and Surgeons of Canada, serving as a member of the Specialty Committee in Neurosurgery, as well as a Royal College surveyor and examiner. He has been an

Dr. David Wilson (Navajo) Appointed Chair of the School’s Department of Indigenous Health at the University of North Dakota

The University of North Dakota (UND) and the School of Medicine & Health Sciences (SMHS) have appointed David R. Wilson, Ph.D., as the inaugural Associate Vice President for Health Research and Chair of the School’s groundbreaking Department of Indigenous Health. Dr. Wilson is set to assume these new roles starting January 1, 2024.

“It is an absolute honor to be selected to continue the outstanding work in health research ongoing at UND’s medical and health sciences college and across the university,” said Dr. Wilson, who was first introduced to the Department as a keynote speaker at the SMHS Indigenous Trauma & Resilience Research Center’s (ITRRC) first annual symposium in 2022.

A tribal citizen of the Navajo Nation with affiliations to Tódich’ii’nii (Bitter Water Clan) and Honágháahnii (One-Walks-Around Clan), Dr. Wilson joins UND from Washington D.C., where he served as a senior policy advisor with the White House Council on Native American Affairs. He previously held the position of the inaugural Director of the National Institutes of Health’s (NIH) Tribal Health Research Office.

Enjoying Native News Coverage?

NNO Logo
Make A Donation Here

In his dual appointment within the office of UND’s Vice President for Research and Economic Development (VPRED) and the School of Medicine & Health Sciences, Dr. Wilson will provide strategic leadership for all aspects of health research across the University and specifically within the Department of Indigenous Health. As Chair, he will report directly to SMHS Dean Dr. Joshua Wynne and collaborate closely with UND’s new VPRED, Dr. Scott Snyder.

Assuming the role of Professor and Chair, Dr. Wilson will oversee the personnel, administrative, educational, and research operations of the Department of Indigenous Health. Additionally, he will actively contribute as a primary instructor, co-instructor, or guest lecturer for Indigenous Health Ph.D.

Lung cancer specialist named medical oncology department chair at Temple University

August 04, 2023

1 min read


We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Martin J. Edelman, MD, has been appointed the first chair of the department of medical oncology at Lewis Katz School of Medicine at Temple University.

Edelman has been with Fox Chase Cancer Center — part of Temple Health — since 2017. He will continue to serve as chair of the department of hematology/oncology and deputy cancer center director for clinical research at Fox Chase.



Graphic with headshot of Martin J. Edelman, MD



“Collaboration and integration among our faculty and staff at Fox Chase Cancer Center and the larger Temple Health community is critical to our growth and ongoing success. This is why we are so pleased to announce this appointment,” Amy J. Goldberg, MD, FACS, dean at Lewis Katz School of Medicine, said in a press release.

Edelman is recognized for his expertise in lung cancer treatment and research. His work focuses on development of new agents and biomarkers to help personalize treatment.

“Throughout his tenure, he has collaborated effectively with our clinical, scientific and administrative leadership to grow robust therapeutic, clinical research, and translational research programs in hematology and medical oncology while leading the department in aligning emerging national trends with the delivery of care to [patients with cancer],” Robert Uzzo, MD, MBA, FACS, president and CEO of Fox Chase, said in the release.

Dr. Sarah Funnell appointed Associate Dean, Indigenous Health and Chair, Indigenous Health | Faculty of Health Sciences

On the recommendation of Dean Jane Philpott, Teri Shearer, Interim Provost and Vice-Principal (Academic) at Queen’s University has appointed Dr. Sarah Funnell as the inaugural Associate Dean, Indigenous Health and Chair, Indigenous Health for a five-year term, effective September 1, 2023.

Dr. Funnell is currently the Director of Indigenous Health and Assistant Professor, Department of Family Medicine, Queen’s Health Sciences (QHS), and is the Founding Director of the Centre of Indigenous Health Research and Education and Assistant Professor, Department of Family Medicine, University of Ottawa (uOttawa).

In the new role of Associate Dean, Dr. Funnell will strategically guide QHS in its actions to achieve reconciliation. Dr. Funnell will lead efforts to incorporate Indigenous health and cultural perspectives into health education, administration, research, and clinical practice – working in collaboration with Indigenous communities and students that are served by QHS, as well as with other change champions. As a key member of the decanal team, Dr. Funnell will provide guidance and advice to QHS leaders. In conjunction with the new role, Dr. Funnell will establish the Office of Indigenous Health at QHS and will work closely alongside Dr. Colleen Davison, Associate Dean, Equity and Social Accountability.

As Chair, Indigenous Health, Dr. Funnell will develop, conduct, and support scholarship and ways of Indigenous knowing within QHS, and enable interdisciplinary community-oriented knowledge translation, mentorship, and collaboration with Indigenous communities and Queen’s colleagues. Dr. Funnell will also foster and support the education, supervision, and mentorship of learners at all levels and promote continuing professional development for faculty. This Chair was created through a $1 million donation by Dr. Nancy Tatham and her partner Ms. Donna Henderson. 

In addition to her work in Indigenous health and medical education, Dr. Funnell has extensive experience in family medicine and public health. Dr. Funnell’s career in healthcare spans

Back To Top